Our mission is to provide
universal access to ultrasound and
eliminate injuries for sonographers
that perform them.

He has been named one of the top 1,000 researchers of all time by the Webometrics Ranking of World Universities, and as the top cardiology researcher in Australia.

He is the author of more than 20 awarded patents and has launched three successful spin-out biotechnology companies with capital raises in excess of US$100 million and licensing deals of more than US$1 billion.

Andrew is a fully accredited physician and cardiologist in the United Kingdom and Australia, a qualified company director (London Business School MBA, Fellow Australian Institute of Company Directors and Member, Institute of Directors, London) with more than 60 board years of experience.

He holds two higher doctorates (DM, Oxon, and DSc, Imperial) for separate research areas and has held senior offices in 5 major Professional Societies, and has been President of the largest specialist society in his field (the Heart Failure Association).

Adam is an experienced Health Director with a demonstrated history of working in the hospital and healthcare industry. He is skilled in clinical research, charity work, medical education, strategic planning, and lecturing, with a PhD focused in Cardiac Medicine from Imperial College London.

Adam is the clinical driving force behind the RMI tele-robotic ultrasound technology. This venture follows his world-first development of a cardiovascular tele-medicine clinical service via his remote-control operated cardiology program, including Holter monitoring and exercise stress testing, which was deployed across Queensland’s rural health facilities for rural and disadvantaged communities. This work was published in the prestigious New England Journal of Medicine in 2020.

Anthony contributes over 35 years of hands-on commercial and strategic planning experience, along with a strong understanding of supply chains and associated supporting financial services.  He has a substantial global business network, is a long-standing board member of the peak industry body PIPA, and sits on the advisory board of a major international supplier to the water, building and infrastructure sectors.

Anthony’s experience in bringing teams together to plan, execute and sustainably deliver innovative strategic and collaborative industry wide initiatives adds invaluable real world insight to RMI.

His experience includes senior positions with Bank of America Merrill Lynch, JP Morgan and National Australia Bank with experience across multiple geographies, including 10 years based in Asia.

Mathew has extensive corporate finance experience working with major global companies across a wide range of sectors.  This includes having led numerous M&A advisory and financing engagements for both listed and unlisted corporate clients.  In addition, advising clients on corporate strategy, risk management and capital structure optimisation.

Mathew holds a Bachelor of Commerce, a Bachelor of Chemical Engineering, and a Master of Applied Finance all from the University of Melbourne and is a Graduate of the Australian Institute of Company Directors.

Robert has gained his medical device experience with multinational MedTech companies including: Medtronic, Given Imaging (a Medtronic company), Siemens and Philips. He also has over 15 years’ experience in consulting and managing internal teams and vendors. Robert is leading RMI’s delivery and development team and guides RMI on its product strategy and development plans.

Robert’s experience in delivering products to market includes launching over 30 products to market throughout his career, and delivering multimillion programs of up to $500 million in annual revenue. He combines technical and management background with solid digital, multidisciplinary, and agile delivery experience, and worked with global and world class teams in over 10 countries across US, Europe, Israel, Asia, and Australia.